公司介绍：
VALIDOGEN (formerly VTU Technology)
Pichia pastoris Protein Expression Excellence
VALIDOGEN, formerly known as VTU Technology, is a leading Austrian contract research and development company. VALIDOGEN offers UNLOCK PICHIA - the broadest toolbox and most versatile technology platform available for Pichia pastoris recombinant protein production. VALIDOGEN develops protein production strains and economically viable protein production processes for the manufacture of biopharmaceuticals, enzymes and various other recombinant proteins. Founded in 2008, the company emerged to a globally recognized player in the field of Pichia pastoris based protein expression.
UNLOCK PICHIA - Productivity through Diversity
Building on Pichia's inherent potential, VALIDOGEN established an exclusive yield-enhancing protein production toolbox, standing out due to its diversity of expression tools and expression strategies. A proprietary AOX1 promoter library and a diverse set of platform strains provide the genetic diversity necessary for fine-tuning of protein expression. Notably, 2nd generation promoter variants from VALIDOGEN's exclusive promoter library offer more flexibility by providing highly productive methanol-free protein production processes. Timely adjusted co-expression of helper proteins allows for maximization of protein yields. VALIDOGEN's unique high-throughput microscale cultivation and screening expertise and protocols ensure fast and reliable identification of the best performing genetic arrangement selected from thousands of Pichia strains assessed in parallel.
VALIDOGEN’s UNLOCK PICHIA technology addresses challenges all the way from transcription and translation to translocation, protein folding and secretion and facilitates the expression of more complex proteins thus maximizing yields without compromising product quality.
SERVICES - Protein Production strains & Processes & Recombinant Proteins
www.validogen.com, www.unlockpichia.com
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息